• 1 January 1985
    • journal article
    • research article
    • Vol. 30  (2) , 77-81
Abstract
This study evaluated the efficacy of the Nd:YAG laser [neodymium: yttrium/aluminun/garnet] (MMB-AT MediLas 2) for early-stage clinical endometriosis. Patients with suspected endometriosis underwent diagnostic laparoscopy, and if mild or moderate pelvic endometriosis was discovered, the lesions were treated with the Nd:YAG laser at a power setting of 20 W with intermittent, 1- to 3-s exposures. All the patients are being treated postoperatively with danazol (800 mg/day) for 3-9mo. At this writing 14 of 24 patients selected for laparoscopy were eligible for treatment with the Nd:YAG laser. Six weeks after treatment all the patients reported relief of their initial symptoms. To date, 2 patients have had repeat laparoscopy after Nd:YAG photocoagulation of mild endometriotic lesions. Neither patient had evidence of disease at the 2nd laparoscopy.